RNAi 技術市場（按應用、最終用戶和地區分類）

2025 年全球 RNAi 技術市場規模估計為 31.1 億美元，預計到 2032 年將達到 82.7 億美元，2025 年至 2032 年的複合年成長率為 15.0%。

數字。 2025 年 RNAi 技術市場佔有率（按地區分類）

全球 RNAi 技術市場的成長是由RNA干擾技術在治療開發和研究中的不斷擴大的應用所推動的。 RNA干擾或RNAi是指由短干擾RNA（siRNA）或微型RNA（miRNA）介導的基因靜默過程。 RNAi 已成為選擇性抑制基因表現和功能基因組學篩選的有力工具。 RNAi 透過定序特定的致病基因，在開發新型治療方法方面具有巨大的潛力。安全有效的輸送系統的開發將進一步促進基於 RNAi 的治療方法的商業化。生物製藥公司和政府組織對 RNAi 研究和開發進行了大量投資，形成了強大的產品平臺。

市場動態

全球 RNAi 技術市場的成長受到 RNAi 技術在整體治療領域治療開發中不斷擴大的應用所推動。目前有幾種針對代謝、心血管和神經退化性疾病的候選藥物正在進行臨床試驗。強大的產品平臺和新型 RNAi 藥物的問世增強了人們對該技術治療潛力的樂觀情緒。然而，RNAi 傳遞中的技術挑戰和脫靶效應可能會阻礙市場成長。此外，建立研發基礎設施和進行臨床開發需要大量的資本投入也限制了許多小型公司的發展。透過脂質奈米顆粒、聚合物奈米顆粒和配體共軛分子等新型遞送系統克服遞送挑戰的持續研究可能為市場成長提供機會。 RNAi 藥物在後期臨床試驗中取得的良好臨床結果可能為市場成長提供機會。

研究的主要特點

• 本報告對全球 RNAi 技術市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模（以十億美元計）和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 全球 RNAi 技術市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
• 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球 RNAi 技術市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員將透過全球 RNAi 技術市場分析中使用的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

4.全球RNAI 技術市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020 年至 2032 年全球 RNAi 技術市場（按應用分類）（十億美元）

• 介紹
• 藥物研發
• 治療
• 神經病學
• 腫瘤學
• 感染疾病
• 代謝紊亂
• 其他
• 功能基因體學
• 其他

6. 2020 年至 2032 年全球 RNAi 技術市場（按最終用戶分類）（十億美元）

• 介紹
• 製藥和生物技術公司
• 學術研究所
• CRO 和 CMO
• 其他

7. 2020 年至 2032 年全球 RNAi 技術市場（按地區分類）（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭格局

• 公司簡介
  • Alnylam Pharmaceuticals
  • OriGene Technologies, Inc.
  • Arrowhead Pharmaceuticals
  • Dicerna Pharmaceuticals
  • Silence Therapeutics
  • Ionis Pharmaceuticals
  • Merck & Co.
  • Qiagen NV
  • Thermo Fisher Scientific
  • Synlogic
  • Benitec Biopharma
  • Gradalis
  • Sirnaomics, Inc.
  • Marina BIoTech
  • Quark Pharmaceuticals
  • Regulus Therapeutics
  • GeneCare Research Institute Co., Ltd.
  • ASC Therapeutics
• 興衰
• 一致的機會地圖

第9章參考文獻與調查方法

• 參考
• 調查方法

Global Rnai Technology Market is estimated to be valued at USD 3.11 Bn in 2025 and is expected to reach USD 8.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.0% from 2025 to 2032.

Figure. Rnai Technology Market Share (%), By Region 2025

Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene silencing mediated by short interfering RNAs (siRNAs) or microRNAs (miRNAs). It has emerged as a powerful tool for selective inhibition of gene expression and functional genomics screens. RNAi holds immense potential for developing novel therapeutics by silencing specific disease-causing genes. The development of safe and effective delivery systems further contributes to the commercialization of RNAi-based therapies. Significant investments in RNAi research and development from biopharma companies and government organizations are resulting in a strong product pipeline.

Market Dynamics:

Global RNAi technology market growth is driven by increasing applications of RNAi technology for developing treatments across therapeutic areas. Several drug candidates targeting metabolic, cardiovascular and neurodegenerative disorders are currently under clinical trials. The strong product pipeline and entry of novel RNAi drugs are creating high optimism around the therapeutic potential of this technology. However, technical challenges in RNAi delivery and off-target effects can hamper the market growth. Moreover, requirement of high capital investments for building R&D infrastructure and clinical development deters many small companies. Ongoing research on overcoming the delivery challenges through novel delivery systems such as lipid nanoparticles, polymeric nanoparticles and ligand-conjugated molecules can offer market growth opportunities. Promising clinical outcomes of RNAi-based drugs in late-stage trials can offer market growth opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global RNAi technology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global RNAi technology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Mirna Therapeutics, and Quark Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global RNAi technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global RNAi technology market

Detailed Segmentation-

• By Application
  • Drug Discovery and Development
  • Therapeutics
  • Neurology
  • Oncology
  • Infectious Diseases
  • Metabolic Diseases
  • Others
  • Functional Genomics
  • Other
• By End User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CMOs
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Alnylam Pharmaceuticals
  • OriGene Technologies, Inc.
  • Arrowhead Pharmaceuticals
  • Dicerna Pharmaceuticals
  • Silence Therapeutics
  • Ionis Pharmaceuticals
  • Merck & Co.
  • Qiagen N.V.
  • Thermo Fisher Scientific
  • Synlogic
  • Benitec Biopharma
  • Gradalis
  • Sirnaomics, Inc.
  • Marina Biotech
  • Quark Pharmaceuticals
  • Regulus Therapeutics
  • GeneCare Research Institute Co., Ltd.
  • ASC Therapeutics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Rnai Technology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global RNAi Technology Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Drug Discovery and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
• Oncology
• Infectious Diseases
• Metabolic Diseases
• Others
• Functional Genomics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global RNAi Technology Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• CROs & CMOs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global RNAi Technology Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Alnylam Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OriGene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arrowhead Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dicerna Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Silence Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ionis Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Qiagen N.V.
  • Thermo Fisher Scientific
  • Synlogic
  • Benitec Biopharma
  • Gradalis
  • Sirnaomics, Inc.
  • Marina Biotech
  • Quark Pharmaceuticals
  • Regulus Therapeutics
  • GeneCare Research Institute Co., Ltd.
  • ASC Therapeutics
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact